Cancer's protective shield: Blocking a signaling pathway could make small cell lung tumors visible to T cells
An international research team led by Dr. Lucia Torres Fernández from the working groups of Professor Dr. Julie George and Professor Dr. Roman Thomas at the University of Cologne has identified a critical dependency in small cell lung cancer (SCLC) that can be exploited therapeutically.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
